Should You Continue to Hold Legend Biotech Corporation (LEGN)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Legend Biotech Corporation (LEGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 6,264,707 | $376,947,420 | 5.88% | |
| 2. | Hillhouse Capital Management Lei Zhang | 5,984,550 | $360,090,374 | -8% | 7.25% |
| 3. | Holocene Advisors Brandon Haley | 1,760,697 | $105,941,138 | +39% | 0.41% |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,370,476 | $82,461,541 | -27% | 0.5% |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 685,000 | $41,216,450 | -30% | 1.5% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,797,994 | $770,055,299 | 0.05% | |
| 2. | 5,266,188 | $316,866,533 | 0% | |
| 3. | 2,385,960 | $143,563,213 | 0.02% | |
| 4. | 2,306,391 | $138,775,547 | 0.02% | |
| 5. | 1,984,826 | $119,426,981 | 0.03% |
News See All
Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript
Operator: Good day, and welcome to Legend Biotech Reports Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
5 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 5 most promising healthcare stocks according to analysts.
Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2023 Financial Results Conference Call.
Should You Expect Strong Financial Growth from Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Opportunity Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Hold Legend Biotech Corporation (LEGN)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
